Type 3c Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 3c Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: An Exploratory Clinical Study Evaluating Allogeneic iPSC-derived Pancreatic Islet Cells (CRG-002) for the Treatment of Diabetic Patients With Hypoglycemia Unawareness or Severe Hypoglycemic Events [EARLY_Phase 1]
An early-phase exploratory study evaluating CRG-002, an allogeneic iPSC-derived pancreatic islet cell therapy, for treating hypoglycemia una…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Development and Validation of a Risk Prediction Model for New-Onset Diabetes After Pancreatectomy
A completed clinical trial update describing the development and validation of a risk prediction model for identifying individuals at risk o…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Clinical Study on the Safety and Efficacy of Immunophenotyped Pancreatic Endocrine Organoid Bank in Treating Patients With T3c Diabetes [EARLY_Phase 1]
An EARLY Phase 1 clinical study is investigating the safety and efficacy of an immunophenotyped pancreatic endocrine organoid bank for treat…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Metformin and Insulin to Pancreatic Cancer Related Diabetes (Type 3c) [Phase 2]
A Phase 2 clinical trial from Fudan University evaluating metformin and insulin in patients with pancreatic cancer–related diabetes (Type 3c…
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: The Use of Islet Organoids in the Treatment of Pancreatic Surgery-related Diabetes [NA]
A study funded by Zhejiang University is evaluating the use of islet organoids to treat pancreatogenic (Type 3c) diabetes mellitus following…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.